Our data showed that overexpression of KAT2B significantly decreased the mRNA level of YAP downstream genes (including CYR61, EDN1, AXL, BIRC6) in CCA cells (Fig. 6B). The gene discussed is KAT2B; the disease is cholangiocarcinoma.